Issued Patents All Time
Showing 1–25 of 159 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12403141 | Deuterated MK2 pathway inhibitors and methods of using the same | David R. Anderson | 2025-09-02 |
| 12384757 | Methods of synthesizing substituted pyridinone-pyridinyl compounds | John Robert Springer | 2025-08-12 |
| 12370195 | Oral compositions of MK2 pathway inhibitor for treatment of immune conditions | Walter P. Smith, Joseph B. Monahan, Edward Hellriegel, David Gordon, Heidi Hope +1 more | 2025-07-29 |
| 12076324 | Cancer treatments using combinations of CDK and ERK inhibitors | Saurabh Saha, Dean Welsch, Jeffrey James Roix | 2024-09-03 |
| 11851498 | Anti-CD276 antibodies (B7H3) | Dimiter S. Dimitrov, Zhongyu Zhu, Bradley St. Croix, Steven Seaman, Saurabh Saha +2 more | 2023-12-26 |
| 11844801 | Oral compositions of MK2 pathway inhibitor for treatment of immune conditions | Walter P. Smith, Joseph B. Monahan, Edward Hellriegel, David Gordon, Heidi Hope +1 more | 2023-12-19 |
| 11767309 | Methods of synthesizing substituted pyridinone-pyridinyl compounds | John Robert Springer | 2023-09-26 |
| 11679112 | Cancer treatments using combinations of CDK and ERK inhibitors | Saurabh Saha, Dean Welsch, Jeffrey James Roix | 2023-06-20 |
| 11246859 | Methods and compositions for treating non-ERK MAPK pathway inhibitor-resistant cancers | Saurabh Saha, Dean Welsch, Jeffrey James Roix | 2022-02-15 |
| 11135225 | Cancer treatments using combinations of CDK and ERK inhibitors | Saurabh Saha, Dean Welsch, Jeffrey James Roix | 2021-10-05 |
| 11013743 | Cancer treatments using combinations of CDK and ERK inhibitors | Saurabh Saha, Dean Welsch, Jeffrey James Roix | 2021-05-25 |
| 11007184 | Cancer treatments using combinations of type 2 MEK and ERK inhibitors | Saurabh Saha, Dean Welsch, Jeffrey James Roix | 2021-05-18 |
| 11007183 | Cancer treatments using combinations of PI3K/Akt pathway and ERK inhibitors | Saurabh Saha, Dean Welsch, Jeffrey James Roix | 2021-05-18 |
| 10881646 | Methods and compositions for treating non-ERK MAPK pathway inhibitor-resistant cancers | Saurabh Saha, Dean Welsch, Jeffrey James Roix | 2021-01-05 |
| 10668055 | Cancer treatment using combinations of ERK and RAF inhibitors | Saurabh Saha, Dean Welsch, Jeffrey James Roix | 2020-06-02 |
| 10604582 | Anti-CD276 antibodies (B7H3) | Dimiter S. Dimitrov, Zhongyu Zhu, Bradley St. Croix, Steven Seaman, Saurabh Saha +2 more | 2020-03-31 |
| 10196443 | TEM8 antibodies and their use in treatment and detection of tumors | Dimiter S. Dimitrov, Zhongyu Zhu, Brad St. Croix, Enrique Zudaire, Saurabh Saha +2 more | 2019-02-05 |
| 9765142 | TEM8 antibodies and their use in treatment and detection of tumors | Dimiter S. Dimitrov, Zhongyu Zhu, Brad St. Croix, Enrique Zudaire, Saurabh Saha +2 more | 2017-09-19 |
| RE43802 | α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors | Michael L. Vazquez, Richard A. Mueller, John J. Talley, Daniel P. Getman, John N. Freskos +2 more | 2012-11-13 |
| RE43596 | α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors | Michael L. Vazquez, Richard A. Mueller, John J. Talley, Daniel P. Getman, John N. Freskos +2 more | 2012-08-21 |
| RE42889 | α- and β- amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors | Michael L. Vazquez, Richard A. Mueller, John J. Talley, Daniel P. Getman, John N. Freskos +2 more | 2011-11-01 |
| 7829564 | α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors | Michael L. Vazquez, Richard A. Mueller, John J. Talley, Daniel P. Getman, John N. Freskos +2 more | 2010-11-09 |
| 7531538 | α- and β-Amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors | Michael L. Vazquez, Richard A. Mueller, John J. Talley, Daniel P. Getman, John N. Freskos +2 more | 2009-05-12 |
| 7339078 | Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors | Daniel P. Getman, John N. Freskos, Michael L. Vazquez, James A. Sikorski, Balekudru Devadas +3 more | 2008-03-04 |
| 7320983 | α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors | Michael L. Vazquez, Richard A. Mueller, John J. Talley, Daniel P. Getman, John N. Freskos +2 more | 2008-01-22 |